Tara Lynd
Guntersville, ALNPI 1558378653
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 130 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 25 manufacturers, the largest accounting for just 17.4% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $550 and has fallen 59.3% since, to $224 in 2025.
Across 130 payments — averaging $17.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Supernus Pharmaceuticals, Inc.$389
- Pfizer$389
- Corium, LLC$173
- Tris Pharma Inc$158
- Merck$138
- Seqirus USA Inc$106
- plus $878 from 19 others
What the payments were for
- Food & beverage$2,231100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Supernus Pharmaceuticals, Inc. | 21 | $389 |
| Pfizer | 25 | $389 |
| Corium, LLC | 9 | $173 |
| Tris Pharma Inc | 11 | $158 |
| Merck | 9 | $138 |
| Seqirus USA Inc | 6 | $106 |
| Sanofi Pasteur Inc. | 6 | $85 |
| Kaleo, Inc. | 4 | $77 |
| Sanofi-aventis U.S. LLC | 4 | $73 |
| Alk-abello, Inc | 4 | $71 |
| Sobi, Inc | 5 | $69 |
| AstraZeneca(2 entities) | 3 | $65 |
| Ultragenyx Pharmaceutical Inc. | 3 | $59 |
| Verrica Pharmaceuticals Inc. | 3 | $59 |
| Nestle Healthcare Nutrition Inc. | 3 | $55 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $46 |
| Biomarin Pharmaceutical Inc. | 2 | $38 |
| Sage Therapeutics, LLC | 1 | $26 |
| Ironshore Pharmaceuticals Inc. | 2 | $26 |
| AbbVie | 1 | $25 |
| Novartis | 1 | $24 |
| Acadia Pharmaceuticals Inc | 1 | $20 |
| Shire North American Group Inc | 1 | $20 |
| Mylan Pharmaceuticals Inc. | 1 | $19 |
| Sarepta Therapeutics, Inc. | 1 | $19 |
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.